Repertaxin
- CAS No.
- 266359-83-5
- Chemical Name:
- Repertaxin
- Synonyms
- CS-2395;DF 1681Y;Reparaxin;Reparixin;Repertaxin;REPARIXIN;DF 1681Y;DF 1681Y;REPERTAXIN;Reparixin (Repertaxin;REPERTAXIN;DF 1681Y;REPARAXIN;Repertaxin(R-configuration, free base form)
- CBNumber:
- CB82628350
- Molecular Formula:
- C14H21NO3S
- Molecular Weight:
- 283.39
- MDL Number:
- MFCD18633292
- MOL File:
- 266359-83-5.mol
- MSDS File:
- SDS
| Melting point | 103-105℃ |
|---|---|
| Density | 1.137±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 25 mg/ml) |
| pka | 4.28±0.40(Predicted) |
| form | solid |
| color | White |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
| FDA UNII | U604E1NB3K |
| NCI Drug Dictionary | reparixin |
SAFETY
Risk and Safety Statements
| Signal word | Warning |
|---|---|
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |
Repertaxin price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 464610 | Reparixin | 266359-83-5 | 1mg | $319 | 2021-12-16 | Buy |
| TRC | R144575 | Reparixin | 266359-83-5 | 25mg | $545 | 2021-12-16 | Buy |
| ChemScene | CS-1379 | Reparixin 99.98% | 266359-83-5 | 25mg | $500 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0008154 | (2R)-N-METHANESULFONYL-2-[4-(2-METHYLPROPYL)PHENYL]PROPANAMIDE 95.00% | 266359-83-5 | 5MG | $505.43 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb546075 | Reparixin >98% | 266359-83-5 | 25mg | $402.9 | 2021-12-16 | Buy |
Repertaxin Chemical Properties,Uses,Production
Description
Reparixin (CAS 266359-83-5) is a noncompetitive allosteric inhibitor of IL-8 (CXCL8) activation of CXCR1 and CXCR2 chemokine receptors (IC50?= 1 and 100 nM, respectively). It blocks a number of activities related to IL-8 signaling, including leukocyte recruitment (IC50?= 1 nM) without affecting receptor activation induced by other CXCR1 and CXCR2 agonists.1?In spontaneously hypertensive rats, 5 mg/kg reparixin administered daily for three weeks was shown to reduce blood pressure by inhibiting hypertension-related mediators.2?It attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord.3?Reparixin blockade (100 nM) of CXCR1 has also been used to deplete a cancer stem cell population in human breast cancer cell lines?in vitro.4
Uses
Prevention of delayed graft function in solid organ transplant (CXCL8 inhibitor).
Uses
Reparixin is an inhibitor of CXCR1 and CXCR2 chemokine receptors. Functions as an agent that blocks a range of activities including leukocyte recruitment and IL-8 signaling.
Definition
ChEBI: Reparixin is a monoterpenoid.
References
1) Bertini?et al.?(2004),?Non-competitive allosteric inhibitors of the inflammatory cytokine receptors CXCR1 and CXCR2: prevention of reperfusion injury; Proc. Natl. Acad. Sci. USA,?101?11791 2) Kim?et al. (2011),?Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats; Biol. Pharm. Bull.,?34?120 3) Gorio?et al.?(2007),?Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord; J. Pharmacol. Exp. Ther.,?322?973 4) Ginestier?et al.?(2010),?CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts; J. Clin. Invest.,?120?485
Repertaxin Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 | shawn@hirisunpharm.com | CHINA | 9923 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
| ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
| Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8474 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33349 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131981 | 58 |
| Chembest Research Laboratories Limited | 021-20908456 | sales@BioChemBest.com | China | 6011 | 61 |
| ChengDu TongChuangYuan Pharmaceutical Co.Ltd | 28-83379370 13880556291 | tcy@tcypharm.com | China | 511 | 57 |